For example: Ozempic and Mounjaro may be covered when prescribed for Type 2 diabetes management Wegovy may be covered to reduce the risk of cardiovascular death, heart attack, or stroke in adults with established cardiovascular disease who are overweight or obese Zepbound may be covered for moderate to severe obstructive sleep apnea in adults with obesity Coverage for these approved indications depends on your specific Part D plan's formulary
While it depends on the person and the dose, clinical trials showed that four weeks after starting retatrutide, some people had already lost almost 5% of their body weight
Some patients may experience improvement in reflux symptoms as they lose weight, since obesity is a significant risk factor for GORD
The research is still early , but the mechanistic rationale is compelling
That limitation has now begun to ease with the application of large language models, including systems such as GPT and Gemini, which enable automated classification and standardisation at scale
.png)
